- Report
- September 2026
- 198 Pages
Global
From €3318EUR$3,545USD£2,773GBP
€3687EUR$3,939USD£3,082GBP
- Report
- September 2026
- 199 Pages
Global
From €3318EUR$3,545USD£2,773GBP
€3687EUR$3,939USD£3,082GBP
- Report
- November 2026
- 168 Pages
Global
From €5475EUR$5,850USD£4,577GBP
- Report
- November 2026
- 486 Pages
Global
From €5475EUR$5,850USD£4,577GBP
- Report
- July 2026
- 189 Pages
Global
From €4446EUR$4,750USD£3,716GBP
- Report
- July 2026
- 160 Pages
Global
From €4446EUR$4,750USD£3,716GBP
- Report
- April 2026
- 180 Pages
Global
From €4446EUR$4,750USD£3,716GBP
- Report
- July 2026
- 150 Pages
Global
From €3510EUR$3,750USD£2,934GBP
- Report
- March 2026
- 150 Pages
Global
From €3510EUR$3,750USD£2,934GBP
- Report
- May 2026
- 156 Pages
Global
From €3697EUR$3,950USD£3,090GBP
- Report
- August 2026
- 249 Pages
Global
From €3500EUR$4,006USD£3,028GBP
- Report
- April 2026
- 135 Pages
Global
From €3500EUR$4,006USD£3,028GBP
- Report
- July 2026
- 95 Pages
North America
From €4446EUR$4,750USD£3,716GBP
- Report
- July 2026
- 100 Pages
Asia Pacific
From €4446EUR$4,750USD£3,716GBP
- Report
- September 2026
France
From €4492EUR$4,799USD£3,754GBP
- Report
- September 2026
India
From €4492EUR$4,799USD£3,754GBP
- Report
- April 2025
- 307 Pages
Global
From €4212EUR$4,500USD£3,520GBP
- Report
- May 2025
- 170 Pages
Global
From €5569EUR$5,950USD£4,655GBP
- Report
- August 2025
- 198 Pages
Global
From €3318EUR$3,545USD£2,773GBP
€3687EUR$3,939USD£3,082GBP
- Report
- August 2025
- 189 Pages
Global
From €3318EUR$3,545USD£2,773GBP
€3687EUR$3,939USD£3,082GBP

Gallium-68 is a radioactive isotope used in Nuclear Medicine and Radiopharmacology. It is used in the production of PET (Positron Emission Tomography) radiopharmaceuticals, which are used to diagnose and treat a variety of diseases. Gallium-68 is produced through the irradiation of enriched zinc-68 in a nuclear reactor, and is then used to produce a variety of PET radiopharmaceuticals. These radiopharmaceuticals are used to diagnose and treat cancer, heart disease, neurological disorders, and other diseases.
Gallium-68 is a key component of the Nuclear Medicine and Radiopharmacology market, and is used in the production of a variety of PET radiopharmaceuticals. Companies in the market include GE Healthcare, Bracco Imaging, Mallinckrodt Pharmaceuticals, and Lantheus Medical Imaging. Show Less Read more